EuropaBio is Europe's largest and most influential biotech industry group, whose members include leading large-size healthcare and industrial biotechnology companies. EuropaBio is located in Brussels, Belgium. The organisation was initiated in 1996 to represent the interests of the biotechnology industry at the European level, and therefore influence legislation that serves the interests of biotechnology companies in Europe.
VIB is a research institute located in Flanders, Belgium. It was founded by the Flemish government in 1995, and became a full-fledged institute on 1 January 1996. The main objective of VIB is to strengthen the excellence of Flemish life sciences research and to turn the results into new economic growth. VIB spends almost 80% of its budget on research activities, while almost 12% is spent on technology transfer activities and stimulating the creation of new businesses, in addition VIB spends approximately 2% on socio-economic activities. VIB is member of EU-LIFE, an alliance of leading life sciences research centres in Europe.
flanders.bio, founded in 2004, is the networking organisation for the life sciences sector in Flanders and represents and supports around 350 member companies. The key strategic objectives of flanders.bio are knowledge exchange and valorisation, human capital development, internationalization of the cluster activities and visibility, familiarization of the public with products derived from the sector and the further development of a supportive environment for the members of flanders.bio.
Gimv (Euronext Brussels: GIMB ) is a Belgian European investment company with experience in private equity and venture capital. Gimv is listed on Euronext Brussels and manages around 1.5 billion EUR invested in about 60 portfolio companies.
CropDesign is a biotech company located in Ghent, Belgium. The company develops a portfolio of agronomic traits for the global commercial seed markets. It has developed a technology platform to discover genetic traits for the improvement of corn, rice and other plants. Current managing director is Juergen Logemann.
Plant Genetic Systems (PGS), since 2002 part of Bayer CropScience, is a biotech company located in Ghent, Belgium. The focus of its activities is the genetic engineering of plants. The company is best known for its work in the development of insect-resistant transgenic plants.
Science and technology in Flanders, being the Flemish Community and more specifically the northern region of Belgium (Europe), is well developed with the presence of several universities and research institutes. These are strongly spread over all Flemish cities, from Kortrijk and Bruges in the Western side, over Ghent as a major university center alongside Antwerp, Brussels and Leuven to Hasselt and Diepenbeek in the Eastern side.
The Participatiemaatschappij Vlaanderen (PMV) is an independent organization owned by the Flemish government which supports economic investment initiatives in Flanders.
Rudy Dekeyser was until May 2012 the Managing Director of VIB. He was until May 2012 head of the technology transfer team of the institute. He obtained a PhD in molecular biology at the University of Ghent.
Erik Tambuyzer is a Belgian bio-engineer and businessman. He is Chairman of the Board of the Flemish Center for Medical Innovation (CMI).
Hugo Van Heuverswyn is a Belgian molecular biologist, biotech pioneer, entrepreneur and businessman. He has been the chairman of the VIB, Flanders Institute for Biotechnology, since its inception in 1995.
The Bioindustry Park Silvano Fumero (BiPCa) is a Science and Technology Park located in Canavese near Turin in the north-west of Italy. The park was founded to promote and develop biotechnological research, to host companies operating research and development, and pilot production in the life science sector. Companies such as Merck Serono and Bracco chose the Park as the location for their research and development activities.
BioLiège is a Belgian association of academic groups of the University of Liège (Liège) and several biotech companies comprising a biotechnopole. The association groups research and development in areas such as human medicine, pharmaceutical industry, toxicology, veterinary medicine, agriculture and plant biotechnology, water treatment, waste management, biodegradation control and the textile industry. Most of the biotech companies are located in the research park of Liège, close to the university campus of Sart Tilman.
The Biotech Fund Flanders was founded by the Flemish government in 1994 as an instrument to support the creation of new companies, explicitly in biotechnology. It provides venture capital to biotech companies in Flanders (Belgium). The fund has 21.7 million euro of capital and is managed by the GIMV.
Ann Van Gysel is a Belgian scientist and CEO of MEDVIA, a healthcare cluster that supports innovation in Flanders, Belgium.
Cristina Garmendia y Mendizábal is a Spanish biologist and businesswoman. With no previous political career, she was appointed as Minister of Science and Innovation in April 2008 by the President of the Government of Spain, Jose Luis Rodriguez Zapatero.
China has seen double-digit growth in its biotechnology industry and has gone from being one of the slowest to one of the fastest nations in the adoption of new biotechnologies. The biotech sector is seen in China and internationally as a core area of national scientific and economic development. The main national biotech body in the country is the China National Center for Biotechnology Development. The CNCBD is an organization established on November 3, 1983, under the Ministry of Science and Technology with the approval of the State Council. CNCBD is the sole national center to coordinate and implement the national S&T program in Biotechnology and Health.
Life Sciences Foundation (LSF) was a San Francisco-based nonprofit organization that was established in 2011 to collect, preserve, interpret, and promote the history of biotechnology. LSF conducted historical research, maintained archives and published historically relevant materials and information.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on January 4, 2016. Biotechnology Innovation Organization serves more than 1,100 biotechnology firms, research schools, state biotechnology centers and related associations in the United States and in more than 30 other countries.
BIOTECanada, previously the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.
